Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22991347 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Platelet Reactivity After TAVI: A Multicenter Pilot Study
Conditions: Severe Aortic Valve Stenosis;   Transcatheter Aortic Valve Implantation;   Transcatheter Aortic Valve Replacement
Interventions: Drug: Ticagrelor 90 mg twice per day during three months following TAVI;   Drug: Aspirin 100 mg plus Clopidogrel 75 mg daily during three months following TAVI
2 Completed
Has Results
A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel

Indicates status has not been verified in more than two years